Sanctuary Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Sanctuary Advisors's HALO Position: Q2 2026 in Review
Sanctuary Advisors increased its Halozyme (HALO) stake by 52% in Q2 2026, buying an estimated $457K and bringing the position to 19,611 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #1189.
Sanctuary Advisors first reported a position in HALO in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.07M in Q1 2025. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Sanctuary Advisors held 19,611 shares of Halozyme worth $1.53M as of Q2 2026.
- Sanctuary Advisors bought 6,704 Halozyme shares in Q2 2026, an estimated $457K.
- Halozyme made up 0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1189 holding.
- Sanctuary Advisors first reported a position in Halozyme in Q2 2024 and has held it in 9 quarters since.
- Sanctuary Advisors's Halozyme position peaked at $2.07M in Q1 2025.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.